- Home
- ASC vs HQL Comparison
ASC vs HQL Comparison
Compare ASC & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASC
- HQL
- Stock Information
- Founded
- ASC 2010
- HQL 1992
- Country
- ASC Bermuda
- HQL United States
- Employees
- ASC 936
- HQL N/A
- Industry
- ASC Marine Transportation
- HQL Investment Managers
- Sector
- ASC Consumer Discretionary
- HQL Finance
- Exchange
- ASC Nasdaq
- HQL Nasdaq
- Market Cap
- ASC 409.5M
- HQL 369.6M
- IPO Year
- ASC 2013
- HQL N/A
- Fundamental
- Price
- ASC $10.20
- HQL $13.00
- Analyst Decision
- ASC Buy
- HQL
- Analyst Count
- ASC 3
- HQL 0
- Target Price
- ASC $13.67
- HQL N/A
- AVG Volume (30 Days)
- ASC 661.3K
- HQL 120.9K
- Earning Date
- ASC 07-30-2025
- HQL 01-01-0001
- Dividend Yield
- ASC 9.32%
- HQL 11.56%
- EPS Growth
- ASC N/A
- HQL N/A
- EPS
- ASC 2.30
- HQL 0.79
- Revenue
- ASC $373,479,000.00
- HQL N/A
- Revenue This Year
- ASC N/A
- HQL N/A
- Revenue Next Year
- ASC N/A
- HQL N/A
- P/E Ratio
- ASC $4.23
- HQL $17.08
- Revenue Growth
- ASC N/A
- HQL N/A
- 52 Week Low
- ASC $8.32
- HQL $11.34
- 52 Week High
- ASC $22.72
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- ASC 56.33
- HQL 61.06
- Support Level
- ASC $9.53
- HQL $12.72
- Resistance Level
- ASC $10.21
- HQL $12.87
- Average True Range (ATR)
- ASC 0.39
- HQL 0.21
- MACD
- ASC -0.02
- HQL 0.01
- Stochastic Oscillator
- ASC 65.04
- HQL 92.96
About ASC Ardmore Shipping Corporation
Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The Company operates its business in one operating segment, the transportation of refined petroleum products and chemicals.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.